It is well-known that type 2 endometrial cancer has poorer clinical outcomes and prognosis compared to type 1 endometrial cancer, however to date whether there is a difference in the positivity of GPR30 between type 1 and type 2 endometrial cancer has not been investigated yet. The gene discussed is GPER1; the disease is endometrial cancer.